Susquehanna International Group, LLP Gracell Biotechnologies Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Gracell Biotechnologies Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 22,600 shares of GRCL stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,600Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GRCL
# of Institutions
2Shares Held
75.1KCall Options Held
0Put Options Held
0About Gracell Biotechnologies Inc.
- Ticker GRCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,674,096
- Description
- Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...